Background Image
Table of Contents Table of Contents
Previous Page  53 / 74 Next Page
Information
Show Menu
Previous Page 53 / 74 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 29, No 6, November/December 2018

AFRICA

385

impact of the different strategies on blood product use was not

assessed as it was beyond the scope of this study.

Only 2.9% of patients received aspirin in the current study,

and the bleeding risk was not assessed because there was no

point-of-care testing. Aspirin has been associated with increased

units of RPC transfused in adult cardiac surgery,

30

but it had no

effect on bleeding and transfusion in paediatric cardiac surgery.

31

The current study was retrospective and depended on the

availability of records and record-keeping by colleagues. The

study did not look at temperature, metabolic state of the patient,

or intra-operative bleeding, which may have contributed to

transfusion rates. The study also did not differentiate between

cyanotic and acyanotic cardiac lesions as data were not clear

on this. Further studies should be conducted to demonstrate

whether there is a relationship between our practice and

morbidity and mortality rates. Transfusion protocols together

with the utilisation of point-of-care testing should be considered.

Conclusion

The use of RPC units was different between RACHS categories,

while maintaining similar haemoglobin levels, despite the absence

of set transfusion triggers and miniature circuits. The pattern of

haemoglobin maintenance was similar to another study. The

transfusion of other blood products was empirical as no point-

of-care tests were utilised. The use of triggers, algorithms and

point-of-care testing in paediatric cardiac patients may result in

a decreased level of transfusion of blood products.

We thank Helen Perrie and Juan Scribante, and Dr K Vanderdonck for assist-

ing with the research.

References

1.

Gulube S, Moshi G, Ledwaba F. Ensuring the safety of blood transfu-

sion in South Africa.

CME

2008;

26

(5): 251–253. Available from: http://

reference.sabinet.co.za/webx/access/electronic_journals/m_cme/m_cme_

v26_n5_a8.pdf. accessed 15 June 2015.

2.

Sultan N, Rashid A, Abbas SM. Reasons for cancellation of elective

cardiac surgery at Prince Sultan Cardiac Centre, Saudi Arabia.

J Saudi

Heart Assoc

2012;

24

(1): 29–34. doi:10.1016/j.jsha.2011.10.006

3.

Keung CY, Smith KR, Savoia HF, Davidson AJ. An audit of transfu-

sion of red blood cell units in pediatric anesthesia.

Pediatr Anesth

2009;

19

(4): 320–328. doi:10.1111/j.1460-9592.2009.02939.x

4.

Guzzetta NA. Benefits and risks of red blood cell transfusion in pedi-

atric patients undergoing cardiac surgery.

Pediatr Anesth

2011;

21

(5):

504–511. doi:10.1111/j.1460-9592.2010.03464.x

5.

Butterworth JF, Mackey DC, Wasnick JD, Morgan GE, Mikhail MS.

Morgan and Mikhail’s Clinical Anesthesiology

. 5th edn. New York:

McGraw-Hill Medical, 2013.

6.

Szekely A, Cserep Z, Sapi E, Breuer T, Nagy CA, Vargha P,

et al

.

Risks and predictors of blood transfusion in pediatric patients under-

going open heart operations.

Ann Thorac Surg

2009;

87

(1): 187–197.

doi:10.1016/j.athoracsur.2008.09.079

7.

Durandy Y. The impact of vacuum-assisted venous drainage and

miniaturized bypass circuits on blood transfusion in pediatric cardiac

surgery.

Am Soc Artif Intern Organs J

2009;

55

(1): 117–120. doi:10.1097/

MAT.0b013e31819142f1.

8.

Iyengar A, Scipione CN, Sheth P, Ohye RG, Riegger L, Bove EL,

et al

.

Association of complications with blood transfusions in pediatric cardi-

ac surgery patients.

Ann Thorac Surg

2013;

96

(3): 910–916. doi:10.1016/j.

athoracsur.2013.05.003

9.

Kipps AK, Wypij D, Thiagarajan RR, Bacha EA, Newburger JW. Blood

transfusion is associated with prolonged duration of mechanical ventila-

tion in infants undergoing reparative cardiac surgery.

Pediatr Crit Care

Med

2011;

12

(1): 52–56.

10. Agarwal HS, Barrett SS, Barry K, Xu M, Saville BR, Donahue BS,

et al

.

Association of blood products administration during cardiopulmonary

bypass and excessive postoperative bleeding in pediatric cardiac surgery.

Pediatr Cardiol

2015;

36

(3): 459–467. doi:10.1007/s00246-014-1034-z.

11. World Health Organization.The clinical use of blood. Geneva,

Switzerland: World Health Organization: Department of Essential

Health Technologies. AIDE-MEMOIRE for National Health

Programmes, 2003.

12. Singh SP. Strategies for blood conservation in pediatric cardiac surgery.

Ann Card Anaesth

2016;

19

(4): 705–716. doi:10.4103/0971-9784.191562.

13. Hasegawa T, Oshima Y, Maruo A, Matsuhisa H, Tanaka A, Noda

R,

et al.

Intraoperative tranexamic acid in pediatric bloodless cardi-

ac surgery.

Asian Cardiovasc Thorac Ann

2014;

22

(9): 1039–1045.

doi:10.1177/0218492314527991

14. Hübler M, Boettcher W, Koster A, Redlin M, Stiller B, Lange P,

et al

.

Transfusion-free cardiac surgery with cardiopulmonary bypass in a

2.2-kg neonate.

J Card Surg

2005;

20

(2): 180–182. doi:10.1111/j.0886-

0440.2005.200414.x.

15. Boettcher W, Dehmel F, Redlin M, Miera O, Musci M, Cho M-Y,

et al.

Complex cardiac surgery on patients with a body weight of less than

5 kg without donor blood transfusion.

J Extra Corpor Technol

2017;

49

(2): 93–97.

16. Ferraris VA, Brown JR, Despotis GJ, Hammon JW, Reece TB, Saha

SP,

et al

. 2011 Update to the Society of Thoracic Surgeons and the

Society of Cardiovascular Anesthesiologists blood conservation clinical

practice guidelines.

Ann Thorac Surg

2011;

91

(3): 944–982. doi:10.1016/j.

athoracsur.2010.11.078.

17. Wypij D, Jonas RA, Bellinger DC, Del Nido PJ, Mayer Jr JE, Bacha

EA,

et al

. The effect of hematocrit during hypothermic cardiopulmo-

nary bypass in infant heart surgery: Results from the combined Boston

hematocrit trials.

J Thorac Cardiovasc Surg

2008;

135

(2): 355–360.

doi:10.1016/j.jtcvs.2007.03.067

18. Miyaji K, Kohira S, Miyamoto T, Nakashima K, Sato H, Ohara K,

et al

. Pediatric cardiac surgery without homologous blood transfu-

sion, using a miniaturized bypass system in infants with lower body

weight.

J Thorac Cardiovasc Surg

2007;

134

(2): 284–289. doi:10.1016/j.

jtcvs.2007.02.020.

19. Lacroix J, Hébert PC, Hutchison JS, Hume HA, Tucci M, Ducruet T,

et al.

Transfusion strategies for patients in pediatric intensive care units.

N Engl J Med

2007;

356

(16): 1609–1619. doi:10.1056/NEJMoa066240.

20. Jenkins KJ, Gauvreau K, Newburger JW, Spray TL, Moller JH, Iezzoni

LI. Consensus-based method for risk adjustment for surgery for congen-

ital heart disease.

J Thorac Cardiovasc Surg

2002;

123

(1): 110–118.

doi:10.1067/mtc.2002.119064.

21. Jobes DR, Sesok-Pizzini D, Friedman D. Reduced transfusion require-

ment with use of fresh whole blood in pediatric cardiac surgical

procedures.

Ann Thorac Surg

2015;

99

(5): 1706–1711. doi:org/10.1016/j.

athoracsur.2014.12.070.

22. Eaton MP, Iannoli EM. Coagulation considerations for infants and chil-

dren undergoing cardiopulmonary bypass.

Pediatr Anesth

2011;

21

(1):

31–42. doi:10.1111/j.1460-9592.2010.03467.x.

23. Timpa JG, O’Meara LC, Goldberg KG, Phillips JP, Crawford JH,

Jackson KW,

et al.

Implementation of a multidisciplinary bleeding and

transfusion protocol significantly decreases perioperative blood prod-